Cano R.A.
201
Coauthors
15
Documentos
Volumen de publicaciones por año
Cargando gráfico
Año de publicación | Num. Publicaciones |
---|---|
2007 | 3 |
2008 | 5 |
2010 | 5 |
2013 | 1 |
2021 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
Área de conocimiento | Num. Publicaciones |
---|---|
Medicina interna | 6 |
Farmacología | 4 |
Bioquímica | 4 |
Fisiología | 3 |
Diabetes | 3 |
Enfermedad cardiovascular | 3 |
Medicamento | 2 |
Metabolismo | 2 |
Nutrición | 1 |
Toxicología | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
Área temática | Num. Publicaciones |
---|---|
Enfermedades | 12 |
Farmacología y terapéutica | 9 |
Fisiología humana | 9 |
Salud y seguridad personal | 4 |
Medicina y salud | 1 |
Medicina forense; incidencia de enfermedades | 1 |
Principales fuentes de datos
Origen | Num. Publicaciones |
---|---|
Scopus | 15 |
Google Scholar | 1 |
RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
Coautor | Num. Publicaciones |
---|---|
Valmore Bermúdez | 15 |
Cano-Ponce C. | 9 |
Arráiz N. | 7 |
Velasco M. | 7 |
Contreras F. | 6 |
Rojas-Quintero J. | 5 |
Mengual-Moreno E. | 5 |
Hernández-Hernandez R. | 5 |
Leal E.M. | 5 |
Finol F. | 4 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Lactitol increases reduced glutathione and decreases nitric oxide in Sprague Dawley rats
ArticleAbstract: Sugar alcohols such as lactitol are increasingly being used in the food industry. Tissue oxidative sPalabras claves:GSH, Lactitol, Nitric oxide, Redox markersAutores:Cano J.R., Cano R.A., Cano-Ponce C., Escalona D., Medina M.T., Valmore Bermúdez, Vargas M.E.Fuentes:scopusMetabolic and hemodynamic markers of endothelial dysfunction in patients with hypertension and patients with type 2 diabetes during the cold pressor test
ArticleAbstract: Leptin, a 167-amino acid peptidic hormone secreted by adipose tissue, acts mainly in the arcuate hypPalabras claves:C-Reactive protein, Hypertension, leptin, Nitric oxide, Type 2 DiabetesAutores:Arráiz N., Cano R.A., Contreras F., Fouillioux C., Lares M., Leal E.M., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopusEffect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects
ArticleAbstract: Dopamine agonists play an important role in the regulation of the central nervous-cardiovascular, rePalabras claves:dopamine, Dopaminergic agonists, Dopaminergic receptors, Hypertension, Insulin, Type 2 Diabetes mellitusAutores:Bolívar H., Cano R.A., Contreras F., Foullioux C., Lares M., Leal E.M., Maroun C., Pacheco B., Valmore Bermúdez, Velasco M.Fuentes:scopusHaemodynamical variables versus endothelial hormones in hypertensive and type 2 diabetic patients with endothelial dysfunction
ArticleAbstract: Leptin is a 167 aminoacid peptidic hormone secreted by adipose tissue. It works mainly in the hypothPalabras claves:C reactive protein, Hypertension, leptin, Nitric oxide, Type 2 Diabetes mellitusAutores:Cano R.A., Contreras F., Fouillioux C., González M.C., Gotera D., Lares M., Magaldi L., Mayda C.L., Pacheco B., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopus